We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Metformin: an update.
- Authors
Kirpichnikov, Dmitri; McFarlane, Samy I; Sowers, James R
- Abstract
Metformin is an insulin-sensitizing agent with potent antihyperglycemic properties. Its efficacy in reducing hyperglycemia in type 2 diabetes mellitus is similar to that of sulfonylureas, thiazolidinediones, and insulin. Metformin-based combination therapy is often superior to therapy with a single hypoglycemic agent. The antihyperglycemic properties of metformin are mainly attributed to suppressed hepatic glucose production, especially hepatic gluconeogenesis, and increased peripheral tissue insulin sensitivity. Although the precise mechanism of hypoglycemic action of metformin remains unclear, it probably interrupts mitochondrial oxidative processes in the liver and corrects abnormalities of intracellular calcium metabolism in insulin-sensitive tissues (liver, skeletal muscle, and adipocytes) and cardiovascular tissue.
- Publication
Annals of internal medicine, 2002, Vol 137, Issue 1, p25
- ISSN
1539-3704
- Publication type
Journal Article
- DOI
10.7326/0003-4819-137-1-200207020-00009